Floatz logo

Therapeutic Asset Ratings

414 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Neoantigen Specific Tcr-T Cell Drug Product
Colorectal Cancer
Alaunos TherapeuticsP1/2CC (40)
Opnurasib
Colorectal Cancer
Novartis PharmaceuticalsP1/2CC (40)
Petosemtamab
Colorectal Cancer
Merus B.V.P1/2CC (40)
Pttl
Colorectal Cancer
Neogap Therapeutics ABP1/2CC (40)
Revumenib
Colorectal Cancer
Syndax PharmaceuticalsP1/2CC (40)
Rezatapopt
Colorectal Cancer
PMV Pharmaceuticals, IncP1/2CC (40)
rp-001
Colorectal Cancer
Recurv Pharma IncP1/2CC (40)
s241656
Colorectal Cancer
Institut de Recherches Internationales ServierP1/2CC (40)
Sacituzumab Tirumotecan
Colorectal Cancer
Merck Sharp & Dohme LLCP1/2CC (40)
Sitagliptin
Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1/2CC (40)
SL-28
Colorectal Cancer
Second Life TherapeuticsP1/2CC (40)
tb511
Colorectal Cancer
Twinpig Biolab, Inc.P1/2CC (40)
tc-510
Colorectal Cancer
TCR2 TherapeuticsP1/2CC (40)
TESTOSTERONE UNDECYLATE
Colorectal Cancer
Aminex Therapeutics, Inc.P1/2CC (40)
TQB2930 for injection
Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.P1/2CC (40)
tt-4
Colorectal Cancer
Portage BiotechP1/2CC (40)
tu2218
Colorectal Cancer
TiumBio Co., Ltd.P1/2CC (40)
vb15010
Colorectal Cancer
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.P1/2CC (40)
Vofatamab
Colorectal Cancer
Fusion Pharmaceuticals Inc.P1/2CC (40)
XP-102
Colorectal Cancer
Xynomic Pharmaceuticals, Inc.P1/2CC (40)
XYA02
Colorectal Cancer
XYone Therapeutics, IncP1/2CC (40)
Zirconium Zr 89 Crefmirlimab Berdoxam
Colorectal Cancer
AstraZenecaP1/2CC (40)
Zongertinib
Colorectal Cancer
Boehringer IngelheimP1/2CC (40)
[68ga]ga-oncofap administration
Colorectal Cancer
Philogen S.p.A.P1C (39)
bi 765049
Colorectal Cancer
Boehringer IngelheimP1C (39)
Showing 226 to 250 of 414 assets
PreviousPage 10 of 17Next